You are here

Sandoz

Sandoz plans to enter the Eylea biosimilar race

Clinical Trials Arena

Tue, 08/15/23 - 10:03 am

wet age-related macular degeneration

Biosimilar makers split strategies in bid to take on top-selling Humira

BioPharma Dive

Thu, 07/27/23 - 10:25 am

Boehringer Ingelheim

7 companies are rolling out Humira biosimilars

Drugstore News

Wed, 07/12/23 - 09:44 am

Boehringer Ingelheim

Samsung Bioepsis

Coherus Biosciences

Sanofi blocks Sandoz's Jevtana generic in patent win

Fierce Pharma

Fri, 06/30/23 - 10:16 am

prostate cancer

Sandoz targets barriers to biosimilar accessibility with latest initiative

Pharmaceutical Technology

Thu, 06/15/23 - 07:00 pm

Sandoz hitches its wagon to biosimilars, predicting $3B in sales from pipeline products over next 5 years

Fierce Pharma

Thu, 06/8/23 - 09:29 pm

Novartis brings on 8 business vets for Sandoz's new board, including 4 women

Fierce Pharma

Tue, 05/16/23 - 12:12 pm

women executives

Sandoz taps Evotec in long-term biosimilar development and manufacturing deal

Fierce Pharma

Wed, 05/10/23 - 10:00 am

Novartis spruces up Sandoz—again—by bringing 6 new US generics into the fold

Fierce Pharma

Thu, 05/4/23 - 09:00 pm

Amgen vs. Sandoz: Legal Battle Erupts Over Bone-Strengthening Drug Patents

Yahoo/Benzinga

Wed, 05/3/23 - 10:41 pm

Amgen nabs appeals win against Otezla generics, blocking Sandoz and Zydus copycats until 2028

Fierce Pharma

Thu, 04/20/23 - 11:47 am

Sandoz to pay Allergan, Duke University $39M over eye drug lawsuit, jury says

Endpoints

Mon, 04/3/23 - 10:46 pm

Duke University

Sandoz, betting on biosimilar sales, to build new production plant

BioPharma Dive

Thu, 03/9/23 - 09:15 pm

drug manufacturing

Sandoz files biosimilar of Amgen osteoporosis drug in US

Pharmaphorum

Tue, 02/7/23 - 12:22 pm

Novartis Reports Mixed Bag Q4 Earnings, Forecasts Higher Sales, Profits Ahead Of Sandoz Spin-Off

Yahoo/Benzinga

Wed, 02/1/23 - 10:39 am

Sandoz signs deal for antifungal from Astellas in buff-up of anti-infectives portfolio

Endpoints

Wed, 01/25/23 - 10:44 am

JPM23: Is Novartis weighing respiratory, eye drug sell-offs after Sandoz? Not necessarily, CEO says

Fierce Pharma

Mon, 01/9/23 - 10:43 pm

As CEO Schultz eyes retirement, Teva taps former Sandoz head Francis as its next leader

Fierce Pharma

Mon, 11/21/22 - 10:30 am

Teva Pharmaceutical

Richard Francis

AbbVie puts up fight against Orilissa generics from Sandoz, Teva and others

Endpoints

Mon, 10/31/22 - 04:22 pm

Teva Pharmaceuticals

Sun, Camber join growing list of companies reporting Adderall supply problems

Fierce Pharma

Fri, 10/7/22 - 10:50 am

Pages